Mark Buyyounouski, MD, MS
Stanford University: Professor: Employee
Elsevier: Honoraria; Wolters Kluwer: Honoraria
Mark Buyyounouski is a Professor of Radiation Oncology at Stanford University. Mark is the Director of Genitourinary Cancer and has a research focus on prostate cancer. He was a co-invcestigator in the Fox Chase Phase III trial comparing convetional and hypofractionated radiotherapy for intact prostate cancer. He is also a NRG Oncology primary investigator and lead GU003: A Randomized Phase III Trial Of Hypofractionated Post-Prostatectomy Radiation Therapy (HYPORT) Versus Conventional Post-Prostatectomy Radiation Therapy (COPORT).
Sunday, October 21
5:39 PM – 5:57 PM